30

PharmaResources Shanghai Co LtdSHE 301230 Stock Report

Last reporting period 30 Sep, 2023

Updated 13 Nov, 2024

Last price

Market cap $B

0.561

Micro

Exchange

XSHE - Shenzhen Stock Exchange

301230.SZ Stock Analysis

30

Uncovered

PharmaResources Shanghai Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.561

Dividend yield

1.06 %

Shares outstanding

16.428 B

PharmaResources Shanghai Co Ltd is a China-based company mainly engaged in the development and commercial production of new drugs. The Company's main businesses include drug discovery, process research and development and commercial manufacturing business. The drug discovery business includes medicinal chemistry, synthetic chemistry and pharmacokinetics. The process research and development business includes process chemistry and process development as well as bulk drug research. The commercial manufacturing business includes customized manufacturing of new drugs and the research and development, production and sales of proprietary generic drug products. The Company distributes its products to the United States, India and other countries.

View Section: Eyestock Rating